FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

108453000: Cisatracurium besilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
172987015 Cisatracurium besylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2695347017 Cisatracurium besilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3725571018 Cisatracurium besilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4583201000005115 cisatracuriumbesilat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cisatracurium besilate Is a Product containing cisatracurium (medicinal product) false Inferred relationship Some
Cisatracurium besilate Is a Cisatracurium (substance) false Inferred relationship Some
Cisatracurium besilate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cisatracurium (substance) true Inferred relationship Some
Cisatracurium besilate Is a Benzylisoquinolium compound true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cisatracurium besylate 2mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
Cisatracurium besylate 10mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
Cisatracurium besylate 20mg/10mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
cisatracuriumbesilat 2 mg/ml injektionsvæske, opløsning, ampul a 2,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
cisatracuriumbesilat 2 mg/ml injektionsvæske, opløsning, ampul a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
cisatracuriumbesilat 2 mg/ml injektionsvæske, opløsning, ampul a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cisatracurium besilate Inferred relationship Some
Product containing precisely cisatracurium (as cisatracurium besilate) 5 milligram/2.5 milliliter conventional release solution for injection ampule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cisatracurium besilate Inferred relationship Some 1
Product containing precisely cisatracurium (as cisatracurium besilate) 10 milligram/5 milliliter conventional release solution for injection ampule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cisatracurium besilate Inferred relationship Some 1
Product containing precisely cisatracurium (as cisatracurium besilate) 20 milligram/10 milliliter conventional release solution for injection ampule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cisatracurium besilate Inferred relationship Some 1
Product containing precisely cisatracurium (as cisatracurium besilate) 2 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cisatracurium besilate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start